Cargando…

Current Nutritional Therapies in Inflammatory Bowel Disease: Improving Clinical Remission Rates and Sustainability of Long-Term Dietary Therapies

Inflammatory Bowel Disease (IBD) includes a spectrum of chronic immune-mediated intestinal diseases thought to be related to the complex interaction between the host immune system and the intestinal microbiome. Research supports the use of nutritional therapy in IBD; however, it is not routinely use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reznikov, Elizabeth A., Suskind, David L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920576/ https://www.ncbi.nlm.nih.gov/pubmed/36771373 http://dx.doi.org/10.3390/nu15030668

Ejemplares similares

The microbiota in inflammatory bowel disease: current and therapeutic insights
por: Lane, Erin R, et al.
Publicado: (2017)

Complete Long-Term Remission of an Inflammatory Pseudotumor under Corticosteroid Therapy
por: Pfeifer, Lukas, et al.
Publicado: (2011)

Differences in Nutrient Intake with Homemade versus Chef-Prepared Specific Carbohydrate Diet Therapy in Inflammatory Bowel Disease: Insights into Dietary Research
por: Morrison, Alex, et al.
Publicado: (2021)

Dietary Strategies for Maintenance of Clinical Remission in Inflammatory Bowel Diseases: Are We There Yet?
por: Gkikas, Konstantinos, et al.
Publicado: (2020)

Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021)

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
por: Kennedy, N A, et al.
Publicado: (2014)

Improving Clinical Remission Rates in Pediatric Inflammatory Bowel Disease with Previsit Planning
por: Savarino, Jeffrey R., et al.
Publicado: (2016)

Dietary Behaviour and Nutrition in Patients with COPD Treated with Long-Term Oxygen Therapy
por: Mekal, Dominika, et al.
Publicado: (2021)

Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria
por: Svensson, Björn, et al.
Publicado: (2013)

A Review of Dietary Therapy for IBD and a Vision for the Future
por: Green, Nicole, et al.
Publicado: (2019)

Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
por: Lamprecht, Georg, et al.
Publicado: (2015)

Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
por: Neurath, Markus F., et al.
Publicado: (2015)

Care of inflammatory bowel disease patients in remission
por: Raghu Subramanian, Charumathi, et al.
Publicado: (2016)

Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Heart Rate Recovery Is Impaired in Inflammatory Bowel Disease: Active Disease versus Remission
por: Efe, Tolga Han, et al.
Publicado: (2017)

Effectiveness of Dual Biologic or Small Molecule Therapy for Achieving Endoscopic Remission in Refractory Inflammatory Bowel Disease
por: Abdullah, Israa, et al.
Publicado: (2022)

Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease
por: Suskind, David L., et al.
Publicado: (2018)

Combination therapy is not associated with improved rates of clinical or endoscopic remission in patients with inflammatory bowel disease treated with ustekinumab or vedolizumab: a retrospective study
por: Jeffrey, Angus W., et al.
Publicado: (2023)

Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population
por: Principi, Mariabeatrice, et al.
Publicado: (2018)

Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence
por: Misra, Sanghamitra M.
Publicado: (2014)

Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease
por: Hart, Lara, et al.
Publicado: (2021)

An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease
por: Haskey, Natasha, et al.
Publicado: (2017)

Depression symptoms increase the risk for initiation or switching to biologic therapy in pediatric inflammatory bowel disease patients in remission
por: Milo, F., et al.
Publicado: (2023)

Understanding Long-term Remission Off Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Hogan, Susan L., et al.
Publicado: (2019)

Global attitudes on and the status of enteral nutrition therapy for pediatric inflammatory bowel disease
por: Luo, Juan, et al.
Publicado: (2022)

Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity
por: Maeda, Takato, et al.
Publicado: (2022)

High infliximab trough concentrations are associated with sustained histologic remission in inflammatory bowel disease: a prospective cohort study
por: Wilson, Aze, et al.
Publicado: (2021)

Serum biomarkers confirming stable remission in inflammatory bowel disease
por: Kessel, Christoph, et al.
Publicado: (2021)

Impact of an exercise program in children with inflammatory bowel disease in remission
por: Trivić, Ivana, et al.
Publicado: (2022)

The Growing Need to Understand Very Early Onset Inflammatory Bowel Disease
por: Zheng, Hengqi B., et al.
Publicado: (2021)

The Effects of Long-Term Dietary Therapy on Patients with Hypertriglyceridemia
por: Yamanaka, Mizuki, et al.
Publicado: (2019)

The Role of Enteral Nutrition in Patients with Inflammatory Bowel Disease: Current Aspects
por: Triantafillidis, John K., et al.
Publicado: (2015)

Is Long-Term Therapy With Thiopurines Effective for Maintaining Remission in Patients With Moderate-To-Severe Ulcerative Colitis?
por: Jeon, Seong Ran, et al.
Publicado: (2015)

Remission of type 2 diabetes in a hypogonadal man under long-term testosterone therapy
por: Haider, Ahmad, et al.
Publicado: (2017)

Sequential Combination Therapy Leading to Sustained Remission in a Patient with SAPHO Syndrome
por: Huber, C.E, et al.
Publicado: (2009)

Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease
por: Chen, Fengqian, et al.
Publicado: (2021)

Remission and long-term remission of pediatric-onset systemic lupus erythematosus
por: Chen, Yi-Chieh, et al.
Publicado: (2023)

Pharmacologic Management of Monogenic and Very Early Onset Inflammatory Bowel Diseases
por: Levine, Anne E., et al.
Publicado: (2023)

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
por: Lie, Mitchell R. K. L., et al.
Publicado: (2018)

Inflammatory bowel disease: Efficient remission maintenance is crucial for cost containment
por: Actis, Giovanni C, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v1lsg58gqmsrba1djj44chjahs